Iron Deficiency Anemia Treatments
Recommendations for the management of iron deficiency anemia including oral and intravenous iron therapies.
Recommendations for the management of iron deficiency anemia including oral and intravenous iron therapies.
Recommended dosing conversions for anticoagulants such as warfarin, heparin, and dabigatran.
Eflapegrastim is a novel, long-acting G-CSF comprised of 2 protein components, an analogue of G-CSF and an Fc antibody fragment.
These guidelines from ASH, ISTH, NHF, and WFH are intended to support patients, clinicians, and healthcare professionals in their decisions affecting the management of VWD.
The FDA has issued guidance to facilitate the availability of coagulation systems during the COVID-19 pandemic.
Investigators noted the importance of improving educational efforts about the safety and efficacy of matched sibling donor HSCT for children with sickle cell disease.
The FDA has accepted for filing and granted Priority Review to narsoplimab for hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Study results suggest that a higher hemoglobin threshold may lead to more transfusions for preterm infants with anemia but without improving outcomes.
A phase 3 trial suggests higher responses when epoetin alfa is added to lenalidomide in treatment of erythropoietin-refractory myelodysplastic syndromes.
The approval was based on data from the open-label, active-controlled phase 3 ANDROMEDA study.